Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

[Candidemia epidemiology in Córdoba Argentina. Surveillance study of five institutions].

Riera F, Medeot M, Sartori L, Bergallo C, Minoli J, Vilchez V, Sánchez P, Abiega C, Pincheira C, Correa S, Bartoli C, Figueroa M, Montamat M, Spitale N, Minguez A, Caeiro JP.

Rev Fac Cien Med Univ Nac Cordoba. 2014;71(2):89-93. Spanish.

PMID:
25365194
2.

Recommendations for the treatment of osteomyelitis.

Lima AL, Oliveira PR, Carvalho VC, Cimerman S, Savio E; Diretrizes Panamericanas para el Tratamiento de las Osteomielitis e Infecciones de Tejidos Blandos Group.

Braz J Infect Dis. 2014 Sep-Oct;18(5):526-34. doi: 10.1016/j.bjid.2013.12.005. Epub 2014 Apr 1. Review.

3.

[Mucormycosis. Clinical cases and update].

Riera F, Marangoni LD, Allende BL, Allende C, Minoldo E, Martinatto C, Paoletti OA, Bergallo C.

Rev Fac Cien Med Univ Nac Cordoba. 2014;71(4):192-8. Review. Spanish.

PMID:
25927886
4.

FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.

Low DE, File TM Jr, Eckburg PB, Talbot GH, David Friedland H, Lee J, Llorens L, Critchley IA, Thye DA; FOCUS 2 investigators.

J Antimicrob Chemother. 2011 Apr;66 Suppl 3:iii33-44. doi: 10.1093/jac/dkr097.

PMID:
21482568
5.

CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.

Wilcox MH, Corey GR, Talbot GH, Thye D, Friedland D, Baculik T; CANVAS 2 investigators.

J Antimicrob Chemother. 2010 Nov;65 Suppl 4:iv53-iv65. doi: 10.1093/jac/dkq255.

PMID:
21115455
6.

[Pneumonia in H1N1 flu infection patients].

Tarán M, Igarzabal P, Bergallo C, Riera F.

Rev Fac Cien Med Univ Nac Cordoba. 2009;66(3):113-7. Spanish.

PMID:
21138668
7.

Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin.

Bergallo C, Jasovich A, Teglia O, Oliva ME, Lentnek A, de Wouters L, Zlocowski JC, Dukart G, Cooper A, Mallick R; 308 Study Group.

Diagn Microbiol Infect Dis. 2009 Jan;63(1):52-61. doi: 10.1016/j.diagmicrobio.2008.09.001. Epub 2008 Nov 5.

PMID:
18990531
8.

Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia.

Tanaseanu C, Bergallo C, Teglia O, Jasovich A, Oliva ME, Dukart G, Dartois N, Cooper CA, Gandjini H, Mallick R; 308 Study Group; 313 Study Group.

Diagn Microbiol Infect Dis. 2008 Jul;61(3):329-38. doi: 10.1016/j.diagmicrobio.2008.04.009. Epub 2008 May 27.

PMID:
18508226
9.

[Extrapulmonary tuberculosis].

Daín A, Ambasch G, Bergallo C, Lamberghini R, Herrera L, Corres MI.

Rev Fac Cien Med Univ Nac Cordoba. 1986;44(2):21-3. Spanish. No abstract available.

PMID:
3438560
10.

[Disseminated intravascular coagulation in infectious diseases].

Daín AL, Bergallo CE, Sánchez C.

Rev Fac Cienc Med Cordoba. 1974 Apr-Jun;32(2):145-60. Spanish. No abstract available.

PMID:
4468445

Supplemental Content

Loading ...
Support Center